Your browser doesn't support javascript.
loading
Can we use EBV-DNA monitoring to predict disease relapse in EBV-positive hodgkin lymphoma patients?
Spacek, Martin; Hubacek, P; Markova, J; Zajac, M; Vernerova, Z; Kozak, T.
Affiliation
  • Spacek M; Department of Clinical Hematology, University Hospital Kralovske Vinohrady and 3rd Faculty of Medicine, Charles University, Prague, Czech Republic. m.spacek@fnkv.cz
Acta Haematol ; 124(1): 23-6, 2010.
Article in En | MEDLINE | ID: mdl-20606412

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Viral / Hodgkin Disease / Predictive Value of Tests / Herpesvirus 4, Human Type of study: Evaluation_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Acta Haematol Year: 2010 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Viral / Hodgkin Disease / Predictive Value of Tests / Herpesvirus 4, Human Type of study: Evaluation_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Acta Haematol Year: 2010 Document type: Article Affiliation country: